BioSpace News Archive

Arpeggio Biosciences will use its proprietary technology to identify immediate biological and genetic changes promoted by specific drug-target interactions

Increased distribution capacity also prepares Company for future product launches

Company invites individual and institutional investors, as well as advisors, to log-on to view the presentation

SiteOne Therapeutics, Inc., today announced a presentation at the Association for Research in Vision and Opthalmology (ARVO) meeting in Honolulu, Hawaii, April 29 to May 3, 2018.

Study supports use of Omeclamox®-Pak as first-line treatment for H. pylori

Newest West Virginia Facility Takes Number of Pharmacies to 19 Nationwide

The Honourable Ginette Petitpas Taylor, Federal Minister of Health, will hold a media availability in the Foyer of the House of Commons following Question Period at approximately 3:15 PM (EDT), March 27, 2018.

BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), a biopharmaceutical company with a proprietary blood-brain barrier platform delivery technology focused on development of therapeutics for the treatment of brain cancers and neurodegenerative diseases, today announced a key strategic appointment to its senior leadership team with the addition of Caroline Hill, Ph.D., as senior vice president, head of research and development operations.

PharmaMar (MCE: PHM), today announced it will be featured as a presenting company at the 17th Needham & Co Annual Healthcare Conference.

Affiliate of leading integrated delivery network to invest $1 million in TELA Bio to form a strategic partnership in research and education